A synthetic peptide derived from a protein found in human gastric juice. Known for its remarkable tissue healing properties across multiple body systems. FDA classified as Category 2 in 2023, restricting compounding.

TB-500

Healing

A synthetic 17-amino acid fragment of Thymosin Beta-4 (TB-4). Unlike TB-4, TB-500 has a longer half-life (~2-4 days vs ~2 hours) and is the active region responsible for tissue repair and cell migration. Note: Many vendors mislabel TB-4 as 'TB-500' in premixed products.

SemaglutideFDA

Weight Loss

A GLP-1 receptor agonist with multiple FDA approvals including weight loss, T2D, CV risk reduction, and kidney protection. Wegovy pill approved Dec 2025 as first oral GLP-1 for weight loss.

TirzepatideFDA

Weight Loss

A dual GIP/GLP-1 receptor agonist representing the next generation of incretin-based therapies. Shows superior weight loss compared to semaglutide in head-to-head trials. First medication approved for obstructive sleep apnea.

Ready to dive into peptide research?

Explore our comprehensive database and join thousands of researchers worldwide.

Explore Peptides Compare Peptides

Welcome to Peptibase

Why Peptibase?

Research-Based

Constantly Updated

Powerful Tools

Browse Categories

Featured Peptides

Ready to dive into peptide research?

Stay Updated

Stay Updated on Peptide Research